Literature DB >> 21623514

Inhibition activities of polysaccharide (RG4-1) from Gentiana rigescens against RSV.

Xin Li1, Jing-Yu Zhou, Qing-Wei Yang, Yang Chen, Ying-Ai Piao, Hong-Yuan Li.   

Abstract

Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection in infants and young children. With the emergence of drug-resistant strains of RSV, new antiviral agents are needed urgently. Gentiana rigescens is a kind of Chinese herb, belonging to Gentianaceae, which has long been used as a folk medicine for curing inflammation, bacterial infection, viral infection, and so on. In this research, polysaccharide designated RG4-1 was isolated from G. rigescens by hot water extraction, ethanol precipitation, and macroreticular adsorbing resin column chromatography, and its antiviral activity, cytotoxicity, and possible antiviral mechanisms were assayed by cytopathogenic effect inhibition assay, 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, and plaque reduction assay. RG4-1 was a fructose-binding lectin. In host cell cultures, RG4-1 was found to be an effective antiviral component against RSV. It showed good inhibitory effect against RSV when it was added 2 h after virus infection with 50% effective concentration of 12.86 μg/ml. RG4-1 also displayed its direct inactivation, attachment inhibition effect, and penetration inhibition effect against RSV. A time-dependent experiment was set up to confirm that RG4-1 blocked RSV infection at early stages of the infection. But RG4-1 seemed to be ineffective against intracellular virus and viral biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623514     DOI: 10.1080/10286020.2011.573628

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  1 in total

Review 1.  Analytical Methods of Phytochemicals from the Genus Gentiana.

Authors:  Yan Xu; Ying Li; Katherine G Maffucci; Linfang Huang; Rui Zeng
Journal:  Molecules       Date:  2017-11-28       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.